1. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

   • R. Rizzoli
   • J. J. Body
   • on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)

   Original Article 20 January 2012 Pages: 2567 - 2576

   

2. Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

   • R. Rizzoli
   • J. J. Body
   • on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)

   Erratum 03 March 2012 Pages: 2577 - 2577

3. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland

   • K. Lippuner
   • H. Johansson
   • R. Rizzoli

   Original Article 06 January 2012 Pages: 2579 - 2589

   

4. The burden of illness of osteoporosis in Canada

   • J.-E. Tarride
   • R. B. Hopkins
   • R. Goeree

   Original Article Open access 08 March 2012 Pages: 2591 - 2600

   

5. Prevalence of vertebral fracture in oldest old nursing home residents

   • A. Rodondi
   • T. Chevalley
   • R. Rizzoli

   Original Article 01 February 2012 Pages: 2601 - 2606

6. Hormonal and dietary influences on true fractional calcium absorption in women: role of obesity

   • S. A. Shapses
   • D. Sukumar
   • L. Taich

   Original Article 27 January 2012 Pages: 2607 - 2614

   

7. Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women

   • J. K. Virtanen
   • D. Mozaffarian
   • D. Feskanich

   Original Article 21 January 2012 Pages: 2615 - 2624

8. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis

   • H. Wang
   • C. Liu

   Original Article 21 December 2011 Pages: 2625 - 2634

   

9. Expression of endothelial nitric oxide synthase protein is not necessary for mechanical strain-induced nitric oxide production by cultured osteoblasts

   • V. Das-Gupta
   • R. A. Williamson
   • A. A. Pitsillides

   Original Article 09 March 2012 Pages: 2635 - 2647

   

10. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action

    • Y. B. Niu
    • Y. H. Li
    • Q. B. Mei

    Original Article 26 April 2012 Pages: 2649 - 2660

    

11. Heel bone mass of a young South Indian population with a Nigerian population residing in a South Indian suburban neighborhood: a comparative study

    • V. Sapthagirivasan
    • M. Anburajan

    Original Article 14 February 2012 Pages: 2661 - 2669

    

12. Quantification of periarticular demineralization and synovialitis of the hand in rheumatoid arthritis patients

    • L. Naumann
    • K.-G. A. Hermann
    • F. Buttgereit

    Original Article 18 February 2012 Pages: 2671 - 2679

    

13. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?

    • O. Gajic-Veljanoski
    • A. M. Bayoumi
    • A. M. Cheung

    Original Article 08 March 2012 Pages: 2681 - 2692

    

14. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study

    • M. Pazianas
    • B. Abrahamsen
    • R. Graham G. Russell

    Original Article 06 March 2012 Pages: 2693 - 2701

    

15. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy

    • A. M. Sbrocchi
    • F. Rauch
    • L. M. Ward

    Original Article 02 February 2012 Pages: 2703 - 2711

    

16. Autosomal recessive osteopetrosis: report of 41 novel mutations in the TCIRG1 gene and diagnostic implications

    • A. Pangrazio
    • M. E. Caldana
    • C. Sobacchi

    Short Communication 10 January 2012 Pages: 2713 - 2718

    

17. Erratum to: Autosomal recessive osteopetrosis: report of 41 novel mutations in the TCIRG1 gene and diagnostic implications

    • A. Pangrazio
    • M. E. Caldana
    • C. Sobacchi

    Erratum 14 February 2012 Pages: 2719 - 2719

18. Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws

    • Y.-D. Kwon
    • D.-W. Lee
    • D.-Y. Kim

    Short Communication 05 January 2012 Pages: 2721 - 2725

    

19. Teriparatide’s role in the management of bisphosphonate-associated osteonecrosis of the jaw

    • G. Subramanian
    • S. Y. P. Quek

    Letter 10 March 2012 Pages: 2727 - 2728

20. Reply to Subramanian and Quek: Teriparatide’s role in the management of bisphosphonate-associated osteonecrosis of the jaw

    • Y.-D. Kwon
    • D.-Y. Kim

    Letter 14 March 2012 Pages: 2729 - 2730

21. Homoarginine deficiency is associated with increased bone turnover

    • S. Pilz
    • A. Meinitzer
    • W. März

    Letter 14 April 2012 Pages: 2731 - 2732

22. Calcium supplementation, renin, and vascular risk

    • M. F. McCarty

    Letter to the Editor 28 January 2012 Pages: 2733 - 2734